SOHO 2022 Speakers
SOHO 2022 annual meeting boasts internationally recognized experts in the field of hematologic...
Read More
Dissemination (Meeting Coverage)
Why Attend SOHO 2022
September 28-October 1, 2022 is the tenth annual Society of Hematologic Oncology (SOHO) meeting....
Read More
Acute Myeloid Leukemia Remission Rates Based on Body Mass Index
In many research studies, the influence of body mass index (BMI) on the prognosis of individuals...
Read More
Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation: Ivosidenib + Azacitidine versus Placebo + Azacitidine
Isocitrate dehydrogenase 1 (IDH1) mutations are oncogenic factors in acute myeloid leukemia (AML),...
Read More
Oncohematology Patients Admitted to the Intensive Care Unit
Oncohematology (OH) patients are supported by the intensive care unit (ICU). Admission of OH...
Read More
Hematologic Patients with Bone Marrow Aspiration: An Observational Study of Pain and Anxiety
Bone marrow aspiration is a key method for identifying hematologic malignancies, monitoring...
Read More
AML with TP53 mutations and MDS with TP53 mutations share similarities
About 10% of individuals with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have...
Read More
Tumor Suppressor Genes Frequently Altered in Squamous Cell Carcinoma
Tumor suppressor genes, including TP53, TERT, KMT2D, NOTCH1, NOTCH2, and FAT1, were often altered...
Read More
Treatment for Sézary Syndrome Increases
The use of systemic and skin-directed therapies increased among patients with Sézary syndrome...
Read More
High Mortality Risk in Patients With Leukemia Hospitalized With CDI
Among patients with leukemia admitted to the hospital with Clostridioides difficile infection...
Read More
Various Racial Disparities in Patients With TP53m Acute Myeloid Leukemia
Black/Hispanic patients with TP53 mutation (m) acute myeloid leukemia (AML) had worse overall...
Read MoreVarious Racial Disparities in Patients With TP53m Acute Myeloid Leukemia
Black/Hispanic patients with TP53 mutation (m) acute myeloid leukemia (AML) had worse overall survival (OS) compared with White patients, according to study results presented by Talha Badar, MBBS, MD, at the 2022 American...
Read More
Once-Daily Radiotherapy Preferred by Patients With Limited Stage Small Cell Lung Cancer
High-dose, once-daily thoracic radiotherapy (TRT) and standard twice daily TRT were well tolerated...
Read More
Most Patients With Multiple Sclerosis Experience Spasticity Daily
Most patients with MS experience spasticity daily, with varying degrees of severity and duration,...
Read More
Multiple Sclerosis-Related Cognitive Impairment Perceptions Differ Between Patients & Physicians
Factors affecting self-reported cognitive impairment (CI) among patients with multiple sclerosis...
Read More
Quadruple Therapy Phase II Data for EGFR-mutated NSCLC
Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) is a promising regimen for...
Read More
Determining Whether Adding RP1 to Cemiplimab Helps CSCC Patients
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
Acalabrutinib Still Outperforming in R/R CLL: Three-years Follow-up of ASCEND
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
OS benefit seen in 5-year data on ELEVATE-TN trial in CLL
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
Add-on Tiragolumab Doesn’t Improve on Atezolizumab in Extensive Stage Small Cell Lung Cancer
A Late-breaking session at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting,...
Read More